Sanjivani Paranteral Limited. (SANJIVIN.BO)
INR 251.05
(0.3%)
INR 251.05
(0.3%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 208.87 Million INR | 51.73% |
| 2022 | 89.55 Million INR | -15.94% |
| 2021 | 106.53 Million INR | 91.43% |
| 2020 | 55.65 Million INR | 3.44% |
| 2019 | 53.79 Million INR | -14.9% |
| 2018 | 63.21 Million INR | -22.85% |
| 2017 | 81.93 Million INR | -52.47% |
| 2016 | 172.37 Million INR | 123.14% |
| 2015 | 77.25 Million INR | 10.27% |
| 2014 | 70.06 Million INR | -14.54% |
| 2013 | 81.97 Million INR | -17.37% |
| 2012 | 99.2 Million INR | 15.81% |
| 2011 | 85.66 Million INR | 4.24% |
| 2010 | 82.18 Million INR | 38.36% |
| 2009 | 59.4 Million INR | 98.84% |
| 2008 | 29.87 Million INR | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 45.23 Million INR | 1.85% |
| 2024 Q1 | 27.13 Million INR | -41.29% |
| 2023 Q4 | 46.22 Million INR | -12.17% |
| 2023 FY | 135.88 Million INR | 51.73% |
| 2023 Q1 | 42.06 Million INR | 1966.1% |
| 2023 Q2 | 31.56 Million INR | -24.97% |
| 2023 Q3 | 52.62 Million INR | 66.75% |
| 2022 FY | 89.55 Million INR | -15.94% |
| 2022 Q4 | 2.03 Million INR | -92.5% |
| 2022 Q3 | 27.13 Million INR | 1.58% |
| 2022 Q1 | 33.68 Million INR | 43.41% |
| 2022 Q2 | 26.7 Million INR | -20.71% |
| 2021 Q2 | 29.95 Million INR | 26.06% |
| 2021 Q4 | 23.48 Million INR | -19.92% |
| 2021 FY | 106.53 Million INR | 91.43% |
| 2021 Q1 | 23.76 Million INR | 5537.21% |
| 2021 Q3 | 29.32 Million INR | -2.09% |
| 2020 Q3 | 17.27 Million INR | -28.77% |
| 2020 FY | 55.65 Million INR | 3.44% |
| 2020 Q1 | 19.65 Million INR | 210.92% |
| 2020 Q4 | -437.02 Thousand INR | -102.53% |
| 2020 Q2 | 24.25 Million INR | 23.41% |
| 2019 Q2 | 25.61 Million INR | 6.07% |
| 2019 Q4 | -17.72 Million INR | -181.47% |
| 2019 FY | 53.79 Million INR | -14.9% |
| 2019 Q1 | 24.15 Million INR | 166.31% |
| 2019 Q3 | 21.75 Million INR | -15.08% |
| 2018 Q3 | 54.66 Million INR | 109.96% |
| 2018 Q2 | 26.03 Million INR | 37.49% |
| 2018 Q1 | 18.93 Million INR | -90.96% |
| 2018 FY | 63.21 Million INR | -22.85% |
| 2018 Q4 | -36.42 Million INR | -166.62% |
| 2017 Q1 | 68.56 Million INR | -58.89% |
| 2017 FY | 81.93 Million INR | -52.47% |
| 2017 Q2 | 156.43 Million INR | 128.15% |
| 2017 Q3 | 24.48 Million INR | -84.35% |
| 2017 Q4 | 209.54 Million INR | 755.66% |
| 2016 Q1 | 22.11 Million INR | -19.63% |
| 2016 FY | 172.37 Million INR | 123.14% |
| 2016 Q4 | 166.79 Million INR | 219.08% |
| 2016 Q3 | 52.27 Million INR | 159.84% |
| 2016 Q2 | 20.11 Million INR | -9.02% |
| 2015 Q1 | 29.69 Million INR | 99.75% |
| 2015 FY | 77.25 Million INR | 10.27% |
| 2015 Q4 | 27.51 Million INR | 76.69% |
| 2015 Q3 | 15.57 Million INR | -11.53% |
| 2015 Q2 | 17.59 Million INR | -40.74% |
| 2014 Q3 | 17.98 Million INR | -19.7% |
| 2014 FY | 70.06 Million INR | -14.54% |
| 2014 Q4 | 14.86 Million INR | -17.34% |
| 2014 Q1 | 18.09 Million INR | 89.94% |
| 2014 Q2 | 22.39 Million INR | 23.77% |
| 2013 Q3 | 31.91 Million INR | 49.92% |
| 2013 Q4 | 9.52 Million INR | -70.15% |
| 2013 FY | 81.97 Million INR | -17.37% |
| 2013 Q1 | 19.24 Million INR | 6.81% |
| 2013 Q2 | 21.29 Million INR | 10.64% |
| 2012 Q2 | 28.42 Million INR | -0.32% |
| 2012 FY | 99.2 Million INR | 15.81% |
| 2012 Q1 | 28.51 Million INR | 114.85% |
| 2012 Q4 | 18.01 Million INR | -36.61% |
| 2012 Q3 | 28.42 Million INR | 0.0% |
| 2011 Q3 | 41.01 Million INR | 0.0% |
| 2011 FY | 85.66 Million INR | 4.24% |
| 2011 Q4 | 13.27 Million INR | -67.65% |
| 2010 FY | 82.18 Million INR | 38.36% |
| 2009 FY | 59.4 Million INR | 98.84% |
| 2008 FY | 29.87 Million INR | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| ANG Lifesciences India Limited | 219.92 Million INR | 5.025% |
| Bacil Pharma Limited | 1.87 Million INR | -11043.769% |
| BDH Industries Limited | 57.03 Million INR | -266.246% |
| Beryl Drugs Limited | 93.77 Million INR | -122.753% |
| Cian Healthcare Limited | 59.19 Million INR | -252.84% |
| Chemo Pharma Laboratories Limited | 1.94 Million INR | -10628.181% |
| Deccan Health Care Limited | 36.24 Million INR | -476.341% |
| DECIPHER LABS LIMITED | 277.6 Million INR | 24.756% |
| Add-Shop E-Retail Limited | 146.52 Million INR | -42.553% |
| Concord Drugs Limited | 91.83 Million INR | -127.456% |
| Gujarat Terce Laboratories Limited | 132.41 Million INR | -57.74% |
| Gujarat Themis Biosyn Limited | 156.84 Million INR | -33.173% |
| Hindustan Bio Sciences Limited | 2.6 Million INR | -7907.757% |
| Ishita Drugs and Industries Limited | 16.46 Million INR | -1168.462% |
| Jenburkt Pharmaceuticals Limited | 437.2 Million INR | 52.224% |
| KIMIA BIOSCIENCES LIMITED | 149.52 Million INR | -39.698% |
| Kwality Pharmaceuticals Limited | 248.93 Million INR | 16.09% |
| Makers Laboratories Limited | 83.1 Million INR | -151.345% |
| Medi-Caps Limited | 93.11 Million INR | -124.315% |
| MedPlus Health Services Limited | 2.42 Billion INR | 91.383% |
| Panchsheel Organics Limited | 68.15 Million INR | -206.456% |
| Parmax Pharma Limited | 99.31 Million INR | -110.314% |
| Parnax Lab Limited | 80.59 Million INR | -159.179% |
| Patidar Buildcon Limited | 1.81 Million INR | -11433.831% |
| Phaarmasia Limited | 50.52 Million INR | -313.406% |
| PRAVEG LIMITED | 77.18 Million INR | -170.63% |
| Sunil Healthcare Limited | 438.1 Million INR | 52.323% |
| Syschem (India) Limited | 64.13 Million INR | -225.7% |
| Sastasundar Ventures Limited | 846.78 Million INR | 75.333% |
| SHAMROCK INDUSTRIAL CO.LTD. | 1.52 Million INR | -13605.885% |
| Smruthi Organics Limited | 261.73 Million INR | 20.195% |
| Source Natural Foods and Herbal Supplements Limited | 31.85 Million INR | -555.673% |
| SUDARSHAN PHARMA INDUSTRIES LI | 146.09 Million INR | -42.978% |
| Trident Lifeline Limited | 46.87 Million INR | -345.644% |
| Transchem Limited | 8.47 Million INR | -2365.215% |
| Trinity League India Limited | -1.08 Million INR | 19333.673% |
| Tyche Industries Limited | 182.04 Million INR | -14.741% |
| Vikram Thermo (India) Limited | 104.27 Million INR | -100.312% |
| Vista Pharmaceuticals Limited | 20.16 Million INR | -935.791% |
| Vivanza Biosciences Limited | 4.55 Million INR | -4485.679% |
| Zenith Healthcare Limited | 45.97 Million INR | -354.299% |
| Zenlabs Ethica Limited | 57.89 Million INR | -260.787% |
| Mercury Laboratories Limited | 217.24 Million INR | 3.85% |
| SHELTER PHARMA LIMITED | 12.3 Million INR | -1598.124% |
| Vasundhara Rasayans Limited | 145.5 Million INR | -43.552% |
| Bharat Immunologicals & Biologicals Corporation Limited | 184.08 Million INR | -13.47% |
| Roopa Industries Limited | 24.63 Million INR | -747.89% |
| PANJON LTD. | 33.77 Million INR | -518.366% |
| Pharmaids Pharmaceuticals Limited | 76.49 Million INR | -173.064% |
| TIAAN CONSUMER LIMITED | 107 Thousand INR | -195112.79% |
| Anuh Pharma Limited | 263.04 Million INR | 20.592% |
| Crestchem Limited | 50.8 Million INR | -311.156% |
| Emmessar Biotech & Nutrition Limited | 4.32 Million INR | -4732.894% |
| Sandu Pharmaceuticals Limited | 212.9 Million INR | 1.89% |
| Fredun Pharmaceuticals Limited | 360.45 Million INR | 42.052% |
| Trimurthi Limited | 4.81 Million INR | -4241.669% |
| Shukra Pharmaceuticals Limited | 83.05 Million INR | -151.499% |
| Norris Medicines Limited | 18.2 Million INR | -1047.355% |
| Veerhealth Care Limited | 15.38 Million INR | -1257.936% |
| Lactose (India) Limited | 111.66 Million INR | -87.062% |
| OXYGENTA PHARMACEUTICAL LIMITE | 23.78 Million INR | -778.375% |
| Ambalal Sarabhai Enterprises Limited | 280.83 Million INR | 25.622% |
| Gennex Laboratories Limited | 130.37 Million INR | -60.211% |
| Denis Chem Lab Limited | 453.36 Million INR | 53.928% |
| Colinz Laboratories Limited | 31.19 Million INR | -569.523% |
| Godavari Drugs Limited | 359.01 Million INR | 41.818% |
| Zenotech Laboratories Limited | 94.82 Million INR | -120.284% |
| Shree Ganesh Remedies Limited | 104.13 Million INR | -100.584% |
| Bharat Parenterals Limited | 255.97 Million INR | 18.4% |
| Coral Laboratories Limited | 189.75 Million INR | -10.075% |
| Evoq Remedies Limited | 4.51 Million INR | -4524.257% |
| Kerala Ayurveda Limited | 399.64 Million INR | 47.734% |
| KOBO BIOTECH LIMITED | 2.48 Million INR | -8322.487% |
| Natural Capsules Limited | 444.7 Million INR | 53.03% |
| Auro Laboratories Limited | 157.37 Million INR | -32.725% |